Better Therapeutics shares surged in the extended session Monday after the company got FDA approval for its smartphone-based behavioral diabetes therapy.
You are here: Home / Top Stories / The Ratings Game: Better Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatment